Tommi Kaasalainen Euformaticsin toimitusjohtajaksi 21.9.2020

Tommi Kaasalainen appointed as new CEO of Euformatics

Wed, 09/23/2020 - 12:13

Euformatics, a Finnish software company specialising in bioinformatics for genomic applications, has appointed Tommi Kaasalainen as its new CEO as of September 21st 2020. Olli Pasanen has stepped down from the position of CEO but will continue to play an integral role in the operation of the company as Chairman of the Board.

Tommi brings with him a wealth of experience and knowledge from his previous roles in both the health tech and IT sectors and will be responsible for building and driving a new growth strategy for the company.

"I am super-excited to join Euformatics. While getting to know the team during the summer I was really impressed by their depth of expertise. The fact that Euformatics' quality control software is used in the accreditation process of genetics labs speaks for itself", says Tommi Kaasalainen.

Chairman of the Board, Olli Pasanen says "It is great to have Tommi join our team. Euformatics has built a unique SaaS offering for the validation, quality control and interpretation of genetics bioinformatics data. I am confident that Tommi's background in international health tech business will help in growing Euformatics to the next level."

In accepting the position of Euformatics CEO, Tommi brings his experience from a highly successful tenet as Executive Vice President at Innokas Medical, a Finnish medical device company where he was responsible for growing their 25M€ contract design and manufacturing business internationally. His most recent appointment was as CEO of Finnish health tech start-up Nukute, a Finnish medical device start-up focusing on sleep apnoea diagnostics.

Tommi holds a Master of Science degree in Industrial Engineering and Management from Tampere University of Technology from which he received an award for the best master's thesis work in Finland upon graduation. He also holds a second Master of Science degree with honours in the University of Tampere focusing on marketing and software development. Additionally, he has completed Aalto University´s Health Tech Executive program.

Euformatics is a Finnish software company that specialises in high standard bioinformatics tools for genomic data interpretation. Since 2010, Euformatics has been helping medical doctors and molecular genetics laboratories provide better precision medicine for cancer, common or rare disease diagnostics. At present, our core solutions include omnomicsNGS; for clinical analysis and reporting of patient NGS data, and omnomicsQ; for NGS data quality management. For more information about us and our products, please visit https://euformatics.com/